Bioequivalence of Two Formulations of Meropenem Intravenous Injection

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
A randomized, single-dose, two-way crossover study to evaluate bioequivalence of two formulations of meropenem (meropenem intravenous injection 0.5 g) after intravenous infusion in healthy volunteers.
Epistemonikos ID: 80a0c09355ae013252630e30196e6aaad692d5c2
First added on: May 12, 2024